Arbutus Biopharma Stock Options
| ABUS Stock | USD 3.33 0.03 0.91% |
Arbutus Biopharma's latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.67 with a put-to-call open interest ratio of 0.48 over 20 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on March 21st 2025.
Open Interest Against March 21st 2025 Option Contracts
Arbutus Biopharma option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Arbutus Biopharma's lending market. For example, when Arbutus Biopharma's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Arbutus Biopharma, he or she must hedge the risk by shorting Arbutus Biopharma stock over its option's life.
2025-03-21
The chart above shows Arbutus Biopharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Arbutus Biopharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Arbutus Biopharma's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Arbutus Biopharma
Analyzing Arbutus Biopharma's in-the-money options over time can help investors to take a profitable long position in Arbutus Biopharma regardless of its overall volatility. This is especially true when Arbutus Biopharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Arbutus Biopharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Arbutus Biopharma's stock while costing only a fraction of its price.
Arbutus Biopharma Corp In The Money Call Balance
When Arbutus Biopharma's strike price is surpassing the current stock price, the option contract against Arbutus Biopharma Corp stock is said to be in the money. When it comes to buying Arbutus Biopharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Arbutus Biopharma Corp are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Arbutus Current Options Market Mood
Arbutus Biopharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Arbutus Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Arbutus Biopharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Arbutus Biopharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Arbutus contract
Base on the Rule 16, the options market is currently suggesting that Arbutus Biopharma Corp will have an average daily up or down price movement of about 0.1% per day over the life of the 2025-03-21 option contract. With Arbutus Biopharma trading at USD 3.33, that is roughly USD 0.003476. If you think that the market is fully incorporating Arbutus Biopharma's daily price movement you should consider buying Arbutus Biopharma Corp options at the current volatility level of 1.67%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Arbutus |
Purchasing Arbutus Biopharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Arbutus calls. Remember, the seller must deliver Arbutus Biopharma Corp stock to the call owner when a call is exercised.
Arbutus Biopharma Option Chain
When Arbutus Biopharma's strike price is surpassing the current stock price, the option contract against Arbutus Biopharma Corp stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Arbutus Biopharma's option chain is a display of a range of information that helps investors for ways to trade options on Arbutus. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Arbutus. It also shows strike prices and maturity days for a Arbutus Biopharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ABUS250321C00002000 | 131 | 2.0 | 0.95 - 1.65 | 1.44 | In |
Call | ABUS250321C00004000 | 242 | 4.0 | 0.05 - 0.2 | 0.15 | Out |
Call | ABUS250321C00003500 | 1757 | 3.5 | 0.15 - 0.3 | 0.3 | Out |
Call | ABUS250321C00003000 | 1635 | 3.0 | 0.1 - 0.6 | 0.54 | In |
Call | ABUS250321C00002500 | 27 | 2.5 | 0.1 - 4.9 | 0.9 | In |
Call | ABUS250321C00006000 | 330 | 6.0 | 0.0 - 0.15 | 0.06 | Out |
Call | ABUS250321C00005500 | 0 | 5.5 | 0.0 - 0.75 | 0.75 | |
Call | ABUS250321C00005000 | 440 | 5.0 | 0.0 - 0.1 | 0.05 | Out |
Call | ABUS250321C00004500 | 219 | 4.5 | 0.0 - 0.1 | 0.42 | Out |
Call | ABUS250321C00007000 | 6 | 7.0 | 0.0 - 0.35 | 0.15 | Out |
Put | ABUS250321P00002000 | 0 | 2.0 | 0.0 - 0.75 | 0.75 | |
Put | ABUS250321P00004000 | 815 | 4.0 | 0.0 - 3.9 | 0.8 | In |
Put | ABUS250321P00003500 | 1350 | 3.5 | 0.0 - 0.75 | 0.45 | In |
Put | ABUS250321P00003000 | 67 | 3.0 | 0.0 - 0.55 | 0.3 | Out |
Put | ABUS250321P00002500 | 0 | 2.5 | 0.0 - 0.4 | 0.4 | |
Put | ABUS250321P00006000 | 0 | 6.0 | 2.65 - 3.1 | 2.65 | In |
Put | ABUS250321P00005500 | 0 | 5.5 | 1.75 - 4.1 | 1.75 | In |
Put | ABUS250321P00005000 | 0 | 5.0 | 0.0 - 2.6 | 2.6 | In |
Put | ABUS250321P00004500 | 71 | 4.5 | 0.0 - 1.6 | 1.36 | In |
Put | ABUS250321P00007000 | 0 | 7.0 | 3.6 - 4.0 | 3.6 | In |
Arbutus Biopharma Market Cap Over Time
Market Cap |
| Timeline |
Arbutus Total Stockholder Equity
Total Stockholder Equity |
|
Arbutus Biopharma Corporate Management
| BA Esq | General Officer | Profile | |
| Gaston Picchio | Chief Officer | Profile | |
| Lisa Caperelli | Vice Relations | Profile | |
| David CPA | CFO Officer | Profile | |
| William Collier | CEO Pres | Profile | |
| Elizabeth Howard | Gen VP | Profile |
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.